SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

2.

The need for more Latinx participants in Alzheimer's trials is urgent.

3.

Admissions, medical colleges, fees, and eligibility requirements information for the DNB Post Diploma in Radiation Oncology.

4.

Study identifies new approach to protect the brain during radiation therapy

5.

Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot